Search research articles
Contact Us
Filters
Showing results (11-20 of 526) with videos related to
Page
of 53
Sort By:
Blood
|
January 1, 1970
A closed system for large-scale lymphocyte purification
A H Woods
Journal of Clinical Pharmacology
|
September 30, 1998
Problems and opportunities in regulation of benzodiazepines
J H Woods
Arizona Medicine
|
July 1, 1973
The immunology of cancer: avenues to immunotherapy
A H Woods
Current Drug Safety
|
August 1, 2023
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration
Richard H Woods
Clinical Rheumatology
|
June 17, 2026
Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics
Richard H Woods
Pharmacotherapy
|
August 17, 2022
Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study
Richard H Woods
Eye, Ear, Nose & Throat Monthly
|
March 19, 2010
Some reasons for ocular discomfort
R H WOODS
Experimental and Clinical Psychopharmacology
|
September 7, 2000
The next reinforcer: comment on Meisch (2000)
J H Woods
Drug and Alcohol Dependence
|
April 1, 1990
Abuse liability and the regulatory control of therapeutic drugs: untested assumptions
J H Woods
British Medical Journal
|
August 27, 2010
CARCINOMA OF THE LARYNX: EXTIRPATION OF PRIMARY AND SECONDARY GROWTHS: GLANDULAR RECURRENCE: TREATMENT WITH THYROID EXTRACT: DISAPPEARANCE OF GROWTHS
R H Woods
Page
of 53
Search research articles
Search
Showing results (11-20 of 526) with videos related to
Sort By:
Page
of 53
Blood
|
January 1, 1970
A closed system for large-scale lymphocyte purification
A H Woods
Journal of Clinical Pharmacology
|
September 30, 1998
Problems and opportunities in regulation of benzodiazepines
J H Woods
Arizona Medicine
|
July 1, 1973
The immunology of cancer: avenues to immunotherapy
A H Woods
Current Drug Safety
|
August 1, 2023
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration
Richard H Woods
Clinical Rheumatology
|
June 17, 2026
Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics
Richard H Woods
Pharmacotherapy
|
August 17, 2022
Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study
Richard H Woods
Eye, Ear, Nose & Throat Monthly
|
March 19, 2010
Some reasons for ocular discomfort
R H WOODS
Experimental and Clinical Psychopharmacology
|
September 7, 2000
The next reinforcer: comment on Meisch (2000)
J H Woods
Drug and Alcohol Dependence
|
April 1, 1990
Abuse liability and the regulatory control of therapeutic drugs: untested assumptions
J H Woods
British Medical Journal
|
August 27, 2010
CARCINOMA OF THE LARYNX: EXTIRPATION OF PRIMARY AND SECONDARY GROWTHS: GLANDULAR RECURRENCE: TREATMENT WITH THYROID EXTRACT: DISAPPEARANCE OF GROWTHS
R H Woods
Page
of 53